LeMaitre Vascular, Inc. (LMAT)
92.94
+1.08
(+1.18%)
USD |
NASDAQ |
Feb 20, 16:00
92.89
-0.05
(-0.05%)
After-Hours: 20:00
LeMaitre Vascular EPS Diluted (Quarterly) : 0.7528 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 1.030 |
| Accuray, Inc. | -0.1138 |
| Alphatec Holdings, Inc. | -0.1888 |
| Boston Scientific Corp. | 0.4493 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 17.36M |
| Revenue (Quarterly) | 61.05M |
| Total Expenses (Quarterly) | 43.68M |
| Enterprise Value | 1.951B |
| Gross Profit Margin (Quarterly) | 72.92% |
| Profit Margin (Quarterly) | 28.44% |
| Earnings Yield | 2.50% |
| Operating Earnings Yield | 2.87% |
| Normalized Earnings Yield | 2.502 |